According to BioLineRx's latest financial reports the company's current EPS (TTM) is -$1.18. In 2022 the company made an earnings per share (EPS) of -$0.59 an increase over its 2021 EPS that were of -$0.79.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.23 | 107.94% |
2022 | -$0.59 | -25% |
2021 | -$0.79 | -66.67% |
2020 | -$2.37 | -29.41% |
2019 | -$3.35 | -19.05% |
2018 | -$4.14 | -22.22% |
2017 | -$5.33 | -3.57% |
2016 | -$5.52 | -0% |
2015 | -$5.52 | -17.65% |
2014 | -$6.71 | -55.26% |
2013 | -$14.99 | -36.9% |
2012 | -$23.76 | 11.81% |
2011 | -$21.25 | -737.01% |
2010 | $3.34 |